Brian Hitsman, Ph.D.
Affiliations: | 2002 | Rosalind Franklin University of Medicine and Science, North Chicago, IL, United States |
Google:
"Brian Hitsman"Mean distance: 19.11 (cluster 50)
Parents
Sign in to add mentor| Roland J. Erwin | grad student | 2002 | Rosalind Franklin Medical School | |
| (The effects of acute tryptophan depletion on cigarette smoking topography and psychopathologic symptoms in schizophrenia.) | ||||
| Bonnie Spring | grad student | 2002 | Rosalind Franklin Medical School | |
| (The effects of acute tryptophan depletion on cigarette smoking topography and psychopathologic symptoms in schizophrenia.) | ||||
Collaborators
Sign in to add collaborator| Jacqueline Gollan | collaborator | Northwestern School of Medicine |
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Hitsman B, Papandonatos GD, Fox EN, et al. (2024) Effect of early medication adherence on behavioral treatment utilization and smoking cessation among individuals with current or past major depressive disorder. Addictive Behaviors. 151: 107952 |
| Freeman S, Leone F, Mathew AR, et al. (2023) The Need for More Robust Clinical Prevention Approaches to Secondhand Smoke Exposure: Beyond Smoke-Free. Chest. 164: 1084-1086 |
| Gollan JK, Liverant G, Jao NC, et al. (2023) Depression Severity Moderates Reward Learning Among Smokers with Current or Past Major Depressive Disorder in a Smoking Cessation Randomized Clinical Trial. Nicotine & Tobacco Research : Official Journal of the Society For Research On Nicotine and Tobacco |
| Schnoll R, Wileyto EP, Bauer AM, et al. (2023) Seeing Through the Blind: Belief about Treatment Randomization and Smoking Cessation Outcome among People with Current or Past Major Depressive Disorder who Smoke in a Placebo-Controlled Trial of Varenicline. Nicotine & Tobacco Research : Official Journal of the Society For Research On Nicotine and Tobacco |
| Mathew AR, Avery EF, Cox C, et al. (2023) Development of a targeted behavioral treatment for smoking cessation among individuals with Chronic Obstructive Pulmonary Disease. Journal of Behavioral Medicine |
| Carroll AJ, Huffman MD, Wileyto EP, et al. (2023) Change in cardiovascular health among adults with current or past major depressive disorder enrolled in intensive smoking cessation treatment. Journal of Affective Disorders |
| Hitsman B, Papandonatos GD, Gollan JK, et al. (2023) Efficacy and Safety of Combination Behavioral Activation for Smoking Cessation and Varenicline for Treating Tobacco Dependence among Individuals with Current or Past Major Depressive Disorder: A 2x2 Factorial, Randomized, Placebo-Controlled Trial. Addiction (Abingdon, England) |
| Shields PG, Bierut L, Arenberg D, et al. (2023) Smoking Cessation, Version 3.2022, NCCN Clinical Practice Guidelines in Oncology. Journal of the National Comprehensive Cancer Network : Jnccn. 21: 297-322 |
| Schnoll R, Barrila GM, Dalsimer S, et al. (2023) Treatment adherence in a smoking cessation clinical trial for individuals with current or past major depressive disorder: Predictors and association with cessation. Addictive Behaviors. 143: 107686 |
| Cioe PA, Schnoll R, Hoeppner BB, et al. (2022) The Impact of the COVID-19 Pandemic on Stress, Isolation, Smoking Behaviors, and Motivation to Quit in People with HIV Who Smoke. Aids and Behavior |